Current trends in pharmaceutical and how they will affect you as a statistician
What are the bigger trends in the biopharmaceutical industry, which will have an impact for statisticians?
. . . in terms of technology changes?
. . . in terms of regulatory changes?
. . . in terms of political/society changes?
What can statisticians do to prepare for these changes?